Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Buried shallow fault slip from the South Napa earthquake revealed by near-field geodesy.

Brooks BA, Minson SE, Glennie CL, Nevitt JM, Dawson T, Rubin R, Ericksen TL, Lockner D, Hudnut K, Langenheim V, Lutz A, Mareschal M, Murray J, Schwartz D, Zaccone D.

Sci Adv. 2017 Jul 28;3(7):e1700525. doi: 10.1126/sciadv.1700525. eCollection 2017 Jul.

2.

Get healthy together: a program to improve counseling for childhood obesity in community-based WIC clinics.

Lockner DW, Kibbe D, Marley SC, Trowbridge F.

J Health Care Poor Underserved. 2014 May;25(2):771-86. doi: 10.1353/hpu.2014.0085.

PMID:
24858885
3.

Innovative tools help counselors discuss childhood obesity with parents.

Herrera J, Lockner D, Kibbe D, Marley SC, Trowbridge F, Bailey A.

Child Obes. 2013 Apr;9(2):144-9. doi: 10.1089/chi.2012.0095. Epub 2013 Mar 15.

4.

Rapid acceleration leads to rapid weakening in earthquake-like laboratory experiments.

Chang JC, Lockner DA, Reches Z.

Science. 2012 Oct 5;338(6103):101-5. doi: 10.1126/science.1221195.

5.

Low strength of deep San Andreas fault gouge from SAFOD core.

Lockner DA, Morrow C, Moore D, Hickman S.

Nature. 2011 Apr 7;472(7341):82-5. doi: 10.1038/nature09927. Epub 2011 Mar 23.

PMID:
21441903
6.

Motivational interviewing skills are positively associated with nutritionist self-efficacy.

Marley SC, Carbonneau K, Lockner D, Kibbe D, Trowbridge F.

J Nutr Educ Behav. 2011 Jan-Feb;43(1):28-34. doi: 10.1016/j.jneb.2009.10.009. Epub 2010 Oct 8.

PMID:
20934389
7.

Fault weakening and earthquake instability by powder lubrication.

Reches Z, Lockner DA.

Nature. 2010 Sep 23;467(7314):452-5. doi: 10.1038/nature09348.

PMID:
20865001
8.

Evaluation of the BOD POD for estimating percent body fat in collegiate track and field female athletes: a comparison of four methods.

Bentzur KM, Kravitz L, Lockner DW.

J Strength Cond Res. 2008 Nov;22(6):1985-91. doi: 10.1519/JSC.0b013e318185f196.

PMID:
18978611
9.

Dietary intake and parents' perception of mealtime behaviors in preschool-age children with autism spectrum disorder and in typically developing children.

Lockner DW, Crowe TK, Skipper BJ.

J Am Diet Assoc. 2008 Aug;108(8):1360-3. doi: 10.1016/j.jada.2008.05.003.

PMID:
18656577
10.

The impact of folic acid fortification of enriched grains on an elderly population: the New Mexico Aging Process Study.

Sisk ER, Lockner DW, Wold R, Waters DL, Baumgartner RN.

J Nutr Health Aging. 2004;8(3):140-3.

PMID:
15129298
11.

[Undergraduate medical education should be pursued close to patients with "common" complaints].

Lockner D.

Lakartidningen. 2003 Dec 18;100(51-52):4334. Swedish. No abstract available.

PMID:
14756107
12.
13.

[A lot of changes: internal medicine, quo vadis?].

Lockner D.

Lakartidningen. 2000 Feb 16;97(7):751. Swedish. No abstract available.

PMID:
10740387
15.

[Why not a scientific approach in connection with reorganizations?].

Lockner D.

Lakartidningen. 1999 Jun 16;96(24):2954. Swedish. No abstract available.

PMID:
10402799
16.

[Standard heparin versus low-molecular-weight heparin].

Lockner D.

Wien Med Wochenschr. 1999;149(2-4):37-8. German.

PMID:
10378320
17.

Cross-validation of modified fatness-specific bioelectrical impedance equations.

Lockner DW, Heyward VH, Griffin SE, Marques MB, Stolarczyk LM, Wagner DR.

Int J Sport Nutr. 1999 Mar;9(1):48-59.

PMID:
10036341
18.

[Sure, the interns are allowed to take part].

Lockner D.

Lakartidningen. 1998 Jan 21;95(4):255. Swedish. No abstract available.

PMID:
9469949
19.

A 6-month venographic follow-up in 164 patients with acute deep vein thrombosis.

Holmström M, Lindmarker P, Granqvist S, Johnsson H, Lockner D.

Thromb Haemost. 1997 Aug;78(2):803-7.

PMID:
9268175
20.

[Medical education needs restructuring].

Lockner D.

Lakartidningen. 1997 Apr 30;94(18):1692. Swedish. No abstract available.

PMID:
9182174
21.
22.

Reduction of permeability in granite at elevated temperatures.

Moore DE, Lockner DA, Byerlee JD.

Science. 1994 Sep 9;265(5178):1558-61.

PMID:
17801532
23.

Comparison of once-daily subcutaneous Fragmin with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis.

Lindmarker P, Holmström M, Granqvist S, Johnsson H, Lockner D.

Thromb Haemost. 1994 Aug;72(2):186-90.

PMID:
7831649
24.

[No true picture of current medical education].

Lockner D.

Lakartidningen. 1993 Dec 22;90(51-52):4638. Swedish. No abstract available.

PMID:
8264305
25.

Electrical impedance and erythrocyte sedimentation rate (ESR) of blood.

Zhao TX, Lockner D.

Biochim Biophys Acta. 1993 Dec 12;1153(2):243-8.

PMID:
8274493
26.
27.

Bleeding complications and coagulopathy in acute leukaemia.

Törnebohm E, Blombäck M, Lockner D, Egberg N, Paul C.

Leuk Res. 1992 Oct;16(10):1041-8.

PMID:
1405706
28.

Elastase activity in leukaemic cells and plasma in patients with acute leukaemia.

Törnebohm E, Egberg N, Sablica H, Wallin R, Lockner D, Paul C.

Eur J Haematol. 1992 Aug;49(2):98-104.

PMID:
1397247
29.

Fragmin once or twice daily subcutaneously in the treatment of deep venous thrombosis of the leg.

Holmoström M, Berglund MC, Granquist S, Bratt G, Törnebohm E, Lockner D.

Thromb Res. 1992 Jul 1;67(1):49-55.

PMID:
1332213
30.
31.

Elastase activity in leukemic cells.

Törnebohm E, Lockner D, Paul C, Egberg N.

Haemostasis. 1992;22(4):216-20.

PMID:
1468725
32.

Treatment of myelodysplastic syndromes with recombinant human erythropoietin.

Hellström E, Birgegård G, Lockner D, Helmers C, Ost A, Wide L.

Eur J Haematol. 1991 Nov;47(5):355-60.

PMID:
1761122
33.

A Randomized Comparison of Doxorubicin and Doxorubicin-DNA in the Treatment of Acute NonLymphoblastic Leukemia.

Paul C, Tidefelt U, Gahrton G, Björkholm M, Järnmark M, Killander A, Kimby E, Liliemark J, Lindeberg A, Lindquist R, Lockner D, Lönnqvist B, Mellstedt H, Merk K, Palmblad J, Peterson C, Simonsson B, Stalfelt AM, Sundström C, Wadman B, Wedelin C, Udén AM, Öberg G, Öst Å.

Leuk Lymphoma. 1991;3(5-6):355-64. doi: 10.3109/10428199109070279.

PMID:
27467426
34.

Two daily subcutaneous injections of fragmin as compared with intravenous standard heparin in the treatment of deep venous thrombosis (DVT).

Bratt G, Aberg W, Johansson M, Törnebohm E, Granqvist S, Lockner D.

Thromb Haemost. 1990 Dec 28;64(4):506-10.

PMID:
1964751
35.

Fatal pulmonary embolism caused by streptokinase treatment of deep venous thrombosis of the leg?

Holmström M, Bratt G, Törnebohm E, Rhedin AS, Lockner D.

J Intern Med. 1990 Dec;228(6):647-9.

PMID:
2280243
36.
37.

A pilot study; desmopressin (DDAVP) in the treatment of deep venous thrombosis.

Törnebohm E, Bratt G, Granqvist S, Lockner D, Egberg N.

Thromb Res. 1987 Mar 1;45(5):635-43.

PMID:
3109064
38.
39.
40.

Pharmacokinetics of intravenously and subcutaneously administered Fragmin in healthy volunteers.

Lockner D, Bratt G, Törnebohm E, Aberg W.

Haemostasis. 1986;16 Suppl 2:8-10.

PMID:
3744135
41.

Intravenous and subcutaneous administration of Fragmin in deep venous thrombosis.

Lockner D, Bratt G, Törnebohm E, Aberg W, Granqvist S.

Haemostasis. 1986;16 Suppl 2:25-9.

PMID:
3744133
42.

Long-term sequelae of calf vein thrombosis treated with heparin or low-dose streptokinase.

Schulman S, Granqvist S, Juhlin-Dannfelt A, Lockner D.

Acta Med Scand. 1986;219(4):349-57.

PMID:
3521207
43.

A comparison between low molecular weight heparin (KABI 2165) and standard heparin in the intravenous treatment of deep venous thrombosis.

Bratt G, Törnebohm E, Granqvist S, Aberg W, Lockner D.

Thromb Haemost. 1985 Dec 17;54(4):813-7.

PMID:
3911482
44.
45.

Thrombolysis and fibrinolytic parameters during heparin treatment of deep vein thrombosis.

Schulman S, Granqvist S, Wiman B, Lockner D.

Thromb Res. 1985 Sep 1;39(5):607-12.

PMID:
4082103
46.

A human pharmacological study comparing conventional heparin and a low molecular weight heparin fragment.

Bratt G, Törnebohm E, Lockner D, Bergström K.

Thromb Haemost. 1985 Apr 22;53(2):208-11.

PMID:
4024029
47.

Factors and inhibitors of blood coagulation and fibrinolysis in acute nonlymphoblastic leukaemia.

Bratt G, Blombäck M, Paul C, Schulman S, Törnebohm E, Lockner D.

Scand J Haematol. 1985 Apr;34(4):332-9.

PMID:
3858983
49.

Factors and inhibitors of blood coagulation and fibrinolysis in promyelocytic leukemia.

Bratt G, Blombäck M, Lockner D.

Scand J Clin Lab Invest Suppl. 1985;178:81-3. No abstract available.

PMID:
3937221
50.

The duration of oral anticoagulation after deep vein thrombosis. A randomized study.

Schulman S, Lockner D, Juhlin-Dannfelt A.

Acta Med Scand. 1985;217(5):547-52.

PMID:
3895828

Supplemental Content

Loading ...
Support Center